E-LIB Suche - Ergebnisse für: Pauck, David

1

UBE2C promotes leptomeningeal dissemination and is a therap..:

Paisana, Eunice ; Cascão, Rita ; Custódia, Carlos...
Neuro-Oncology Advances. 5 (2023) 1 - p. , 2023

2

Tacedinaline (CI-994), a class I HDAC inhibitor, targets in..:

Marquardt, Viktoria ; Theruvath, Johanna ; Pauck, David...
Journal for ImmunoTherapy of Cancer. 11 (2023) 1 - p. e005871 , 2023

Link: https://doi.org/10.1136/..

3

De novo missense variants in RRAGC lead to a fatal mTORopat..:

Reijnders, Margot R.F. ; Seibt, Annette ; Brugger, Melanie...
Genetics in Medicine. 25 (2023) 7 - p. 100838 , 2023

Link: https://doi.org/10.1016/..

4

BSCI-04 TARGETING THE PI3K-MTOR PATHWAY TO TREAT UBE2C-DRIV..:

Paisana, Eunice ; Cascão, Rita ; Custódia, Carlos...
Neuro-Oncology Advances. 4 (2022) Supplement_1 - p. i1-i2 , 2022

Link: https://doi.org/10.1093/..

5

Primary cilia contribute to the aggressiveness of atypical ..:

Blümel, Lena ; Qin, Nan ; Berlandi, Johannes...
Cell Death & Disease. 13 (2022) 9 - p. , 2022

Link: https://doi.org/10.1038/..

6

Sensitivity towardsHDACinhibition is associated withRTK/MAP..:

Seidlitz, Therese ; Schmäche, Tim ; Garcίa, Fernando...
EMBO Molecular Medicine. 14 (2022) 10 - p. , 2022

Link: https://doi.org/10.15252..

7

The HHIP-AS1 lncRNA promotes tumorigenicity through stabili..:

Bartl, Jasmin ; Zanini, Marco ; Bernardi, Flavia...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

8

The long non-coding RNA HOTAIRM1 promotes tumor aggressiven..:

Ahmadov, Ulvi ; Picard, Daniel ; Bartl, Jasmin...
Cell Death & Disease. 12 (2021) 10 - p. , 2021

Link: https://doi.org/10.1038/..

9

EMBR-13. NOVEL SYNERGISTIC APPROACHES FOR TARGETED THERAPY ..:

Qin, Nan ; Picard, Daniel ; Rickert, Daniel...
Neuro-Oncology. 23 (2021) Supplement_1 - p. i8-i8 , 2021

Link: https://doi.org/10.1093/..

10

LMD-12. Ubiquitin Conjugating Enzymes promote leptomeningea..:

Paisana, Eunice ; Cascão, Rita ; Custódia, Carlos...
Neuro-Oncology Advances. 3 (2021) Supplement_3 - p. iii10-iii10 , 2021

Link: https://doi.org/10.1093/..

11

LGG-17. SYNERGISTIC ACTIVITY OF MAPK INHIBITOR CLASSES REVE..:

Usta, Diren ; Sigaud, Romain ; Buhl, Juliane L...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii369-iii369 , 2020

Link: https://doi.org/10.1093/..

12

Different Calculation Strategies Are Congruent in Determini..:

Fischer, Igor ; Nickel, Ann-Christin ; Qin, Nan...
Cells. 9 (2020) 12 - p. 2689 , 2020

Link: https://doi.org/10.3390/..

13

MBRS-48. IDENTIFICATION OF NOVEL THERAPEUTIC APPROACHES FOR..:

Taban, Kübra ; Pauck, David ; Maue, Mara...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii406-iii406 , 2020

Link: https://doi.org/10.1093/..

14

IMMU-19. HDAC INHIBITORS SENSITIZE MYC-AMPLIFIED MEDULLOBLA..:

Marquardt, Viktoria ; Theruvath, Johanna ; Pauck, David...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii363-iii364 , 2020

Link: https://doi.org/10.1093/..

15

EPEN-33. PHARMACOGENOMICS REVEALS SYNERGISTIC INHIBITION OF..:

Pauck, David ; Paisana, Eunice ; Cascão, Rita...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii314-iii314 , 2020

Link: https://doi.org/10.1093/..